Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Ordinary Share $0.00001 par value
-
Shares outstanding
-
50,588,235
-
Total 13F shares
-
52,961,450
-
Share change
-
-3,890,076
-
Total reported value
-
$1,111,646,885
-
Price per share
-
$20.99
-
Number of holders
-
121
-
Value change
-
-$95,003,651
-
Number of buys
-
74
-
Number of sells
-
37
Institutional Holders of Theravance Biopharma, Inc. - Ordinary Share $0.00001 par value (TBPH) as of Q2 2020
As of 30 Jun 2020,
Theravance Biopharma, Inc. - Ordinary Share $0.00001 par value (TBPH) was held by
121 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
52,961,450 shares.
The largest 10 holders included
FMR LLC, BAUPOST GROUP LLC/MA, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., ORBIMED ADVISORS LLC, AMERIPRISE FINANCIAL INC, NORGES BANK, JANE STREET GROUP, LLC, and STATE STREET CORP.
This page lists
121
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.